Citation Impact
Citing Papers
Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1 H -pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia†Coordinates of the PDE10A crystal structures have been deposited in the Protein Data Bank for compound 1 (3HQW), 2 (3HQY), 3 (3HQW) and 9 (3HR1).
2009
In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter
2010 StandoutNobel
Evaluation of a Pharmacist-Led Medication Assessment Used to Identify Prevalence of and Associations With Polypharmacy and Potentially Inappropriate Medication Use Among Ambulatory Senior Adults With Cancer
2015
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
Randomized, Placebo-Controlled Comparison of Amitriptyline, Duloxetine, and Pregabalin in Patients With Chronic Diabetic Peripheral Neuropathic Pain
2012
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
In Vitro Activities of Tigecycline, Ertapenem, Isepamicin,and Other Antimicrobial Agents Against Clinically IsolatedOrganisms in Taiwan
2005
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
What is polypharmacy? A systematic review of definitions
2017 Standout
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
Oxidative stress and diabetic cardiovascular complications
2005
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Expression of functionally phagocyte‐type NAD(P)H oxidase in pericytes: effect of angiotensin II and high glucose
2005
Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study
2006
Behavioral Disturbance in Dementia
2012
Natural products: An evolving role in future drug discovery
2011 Standout
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
2006 Standout
The metabolic syndrome
2010 Standout
The pathogenesis of cardiac fibrosis
2013 Standout
Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics
2009
Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation
2005
Small molecule vanilloid TRPV1 receptor antagonists approaching drug status: can they live up to the expectations?
2006
Coordinated regulation of myeloid cells by tumours
2012 Standout
Drug and ECT treatment of depression in the elderly, 1996–2001: a literature review
2002
Metformin – a Future Therapy for Neurodegenerative Diseases
2017
Current Antihyperglycemic Treatment Guidelines and Algorithms for Patients with Type 2 Diabetes Mellitus
2010
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
2007 Standout
The paradox of the neutrophilˈs role in tissue injury
2010
Depression in Late Life: Review and Commentary
2003 Standout
Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study
2003
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
A novel mathematical model quantifying drug release from lipid implants
2008
The metabolic syndrome
2005 Standout
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline
2006
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
The Pathogenesis of Myocardial Fibrosis in the Setting of Diabetic Cardiomyopathy
2006
Hypoxia-inducible factor 1α protects peripheral sensory neurons from diabetic peripheral neuropathy by suppressing accumulation of reactive oxygen species.
2018
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Clinical Guideline: Management of Gastroparesis
2012
ORAL PROTEIN KINASE C β INHIBITION USING RUBOXISTAURIN
2011
The Metabolic Syndrome and Cardiovascular Disease: Part 2
2008
The metabolic syndrome—a new worldwide definition
2005 Standout
Tigecycline for Treatment of Pneumonia and Empyema Caused by Carbapenemase‐Producing Klebsiella pneumoniae
2007
Lamotrigine for treatment of pain associated with diabetic neuropathy: Results of two randomized, double-blind, placebo-controlled studies
2006
Type 2 diabetes mellitus
2015 Standout
Recurrent miscarriage
2006 Standout
Cognitive Stimulation in Patients with Dementia: Randomized Controlled Trial
2013 Standout
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
2009 Standout
Physiology and Pathophysiology of Carnosine
2013 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Effect of Initial Combination Therapy With Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, and Metformin on Glycemic Control in Patients With Type 2 Diabetes
2007
Guidelines for the Primary Prevention of Stroke
2014 Standout
Sildenafil (ViagraTM): Synthesis Step by Step and its Pharmaceutical Importance in Diabetic Patients with Erectile Dysfunction
2018
Quality of Life and Objective Measures of Diabetic Neuropathy in a Prospective Placebo-Controlled Trial of Ruboxistaurin and Topiramate
2011
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
2006
The molecular mechanisms of pancreatic β-cell glucotoxicity: Recent findings and future research directions
2012
Wound Healing: A Cellular Perspective
2018 Standout
Mechanisms of Diabetic Complications
2013 Standout
The Metabolic Syndrome
2008 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Ruboxistaurin, a Protein Kinase C β Inhibitor, as an Emerging Treatment for Diabetes Microvascular Complications
2005
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Biochemistry and Physiology of Cyclic Nucleotide Phosphodiesterases: Essential Components in Cyclic Nucleotide Signaling
2007 Standout
Synthesis and biological activity of pyrrole, pyrroline and pyrrolidine derivatives with two aryl groups on adjacent positions
2006 Standout
A Medicinal Chemist’s Guide to Molecular Interactions
2010 Standout
Effect of Initial Combination Therapy With Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, and Metformin on Glycemic Control in Patients With Type 2 Diabetes
2008
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Works of Stephen M. Setter being referenced
Exenatide: An incretin mimetic for the treatment of type 2 diabetes mellitus
2006
Nonsteroidal anti-inflammatory drugs: The need for assessment and education
2001
Depression in community-dwelling elders
1998
Metformin hydrochloride in the treatment of type 2 diabetes mellitus: A clinical review with a focus on dual therapy
2003
Colesevelam hydrochloride for the treatment of type 2 diabetes mellitus
2009
Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease
2010
Tigecycline: An investigational glycylcycline antimicrobialwith activity against resistant gram-positive organisms
2005
Inhaled dry powder insulin for the treatment of diabetes mellitus
2007
Phosphodiesterase 5 Inhibitors for Erectile Dysfunction
2005
Diabetic Neuropathy: An intensive review
2004
Effectiveness of a pharmacist–nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care
2009
Biochemical Pathways for Microvascular Complications of Diabetes Mellitus
2003